Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines
Gespeichert in:
| Veröffentlicht in: | Pharmacoepidemiology and drug safety 2016-02, Vol.25 (2), p.215-222 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 222 |
|---|---|
| container_issue | 2 |
| container_start_page | 215 |
| container_title | Pharmacoepidemiology and drug safety |
| container_volume | 25 |
| creator | Mahaux, Olivia Bauchau, Vincent Van Holle, Lionel |
| description | |
| doi_str_mv | 10.1002/pds.3918 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5063172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3934990001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4768-ded48af961dda04681725eaef07319beb7985350d450a12c33e7f4418fd7c9d73</originalsourceid><addsrcrecordid>eNp1kE1PGzEQhi1UxFcr9RdUK_XCZam9XtvrSyUUvhqFFKkUjpZjz4LpZr3Ym5D8exwlRHDoaUYzj56xX4S-EnxCMC5-dDaeUEmqHXRAsJQ5YUx8WvWM5hXjch8dxviEcdrJcg_tF5zjggh5gG5vHnWYauOhcxamzjf-wRndZMa3MU2C7l3qMtdmfhIhzMHmvc9h0YHpwWa61c0yQsxqH7K5Nsa1ED-j3Vo3Eb5s6hH6e3F-O7jKR78vfw1OR7kpBa9yC7asdC05sVbjkldEFAw01FhQIicwEbJilGFbMqxJYSgFUZclqWorjLSCHqGfa283m0zBGmj7oBvVBTfVYam8durjpnWP6sHPFcOcpmNJ8H0jCP55BrFXT34W0peiIoJjURRY8EQdrykTfIwB6u0FgtUqf5XyV6v8E_rt_Yu24FvgCcjXwItrYPlfkbo5-7MRbngXe1hseR3-KS6oYOp-fKmG4-vhYDw6U3f0Fe-3oKE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760722076</pqid></control><display><type>article</type><title>Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Mahaux, Olivia ; Bauchau, Vincent ; Van Holle, Lionel</creator><creatorcontrib>Mahaux, Olivia ; Bauchau, Vincent ; Van Holle, Lionel</creatorcontrib><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.3918</identifier><identifier>PMID: 26602179</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Animals ; Commentaries ; Data Interpretation, Statistical ; Data Mining - methods ; Humans ; Incidence ; methodology ; Observed-to-expected ; pharmacoepidemiology ; Pharmacoepidemiology - methods ; Uncertainty ; uncertainty analyses ; Vaccines - adverse effects</subject><ispartof>Pharmacoepidemiology and drug safety, 2016-02, Vol.25 (2), p.215-222</ispartof><rights>2015 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd.</rights><rights>Copyright © 2016 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4768-ded48af961dda04681725eaef07319beb7985350d450a12c33e7f4418fd7c9d73</citedby><cites>FETCH-LOGICAL-c4768-ded48af961dda04681725eaef07319beb7985350d450a12c33e7f4418fd7c9d73</cites><orcidid>0000-0001-7354-6475</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpds.3918$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpds.3918$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,315,781,785,886,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26602179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahaux, Olivia</creatorcontrib><creatorcontrib>Bauchau, Vincent</creatorcontrib><creatorcontrib>Van Holle, Lionel</creatorcontrib><title>Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines</title><title>Pharmacoepidemiology and drug safety</title><addtitle>Pharmacoepidemiol Drug Saf</addtitle><subject>Animals</subject><subject>Commentaries</subject><subject>Data Interpretation, Statistical</subject><subject>Data Mining - methods</subject><subject>Humans</subject><subject>Incidence</subject><subject>methodology</subject><subject>Observed-to-expected</subject><subject>pharmacoepidemiology</subject><subject>Pharmacoepidemiology - methods</subject><subject>Uncertainty</subject><subject>uncertainty analyses</subject><subject>Vaccines - adverse effects</subject><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kE1PGzEQhi1UxFcr9RdUK_XCZam9XtvrSyUUvhqFFKkUjpZjz4LpZr3Ym5D8exwlRHDoaUYzj56xX4S-EnxCMC5-dDaeUEmqHXRAsJQ5YUx8WvWM5hXjch8dxviEcdrJcg_tF5zjggh5gG5vHnWYauOhcxamzjf-wRndZMa3MU2C7l3qMtdmfhIhzMHmvc9h0YHpwWa61c0yQsxqH7K5Nsa1ED-j3Vo3Eb5s6hH6e3F-O7jKR78vfw1OR7kpBa9yC7asdC05sVbjkldEFAw01FhQIicwEbJilGFbMqxJYSgFUZclqWorjLSCHqGfa283m0zBGmj7oBvVBTfVYam8durjpnWP6sHPFcOcpmNJ8H0jCP55BrFXT34W0peiIoJjURRY8EQdrykTfIwB6u0FgtUqf5XyV6v8E_rt_Yu24FvgCcjXwItrYPlfkbo5-7MRbngXe1hseR3-KS6oYOp-fKmG4-vhYDw6U3f0Fe-3oKE</recordid><startdate>201602</startdate><enddate>201602</enddate><creator>Mahaux, Olivia</creator><creator>Bauchau, Vincent</creator><creator>Van Holle, Lionel</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>BSCLL</scope><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7354-6475</orcidid></search><sort><creationdate>201602</creationdate><title>Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines</title><author>Mahaux, Olivia ; Bauchau, Vincent ; Van Holle, Lionel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4768-ded48af961dda04681725eaef07319beb7985350d450a12c33e7f4418fd7c9d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Commentaries</topic><topic>Data Interpretation, Statistical</topic><topic>Data Mining - methods</topic><topic>Humans</topic><topic>Incidence</topic><topic>methodology</topic><topic>Observed-to-expected</topic><topic>pharmacoepidemiology</topic><topic>Pharmacoepidemiology - methods</topic><topic>Uncertainty</topic><topic>uncertainty analyses</topic><topic>Vaccines - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahaux, Olivia</creatorcontrib><creatorcontrib>Bauchau, Vincent</creatorcontrib><creatorcontrib>Van Holle, Lionel</creatorcontrib><collection>Istex</collection><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahaux, Olivia</au><au>Bauchau, Vincent</au><au>Van Holle, Lionel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><addtitle>Pharmacoepidemiol Drug Saf</addtitle><date>2016-02</date><risdate>2016</risdate><volume>25</volume><issue>2</issue><spage>215</spage><epage>222</epage><pages>215-222</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>26602179</pmid><doi>10.1002/pds.3918</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-7354-6475</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1053-8569 |
| ispartof | Pharmacoepidemiology and drug safety, 2016-02, Vol.25 (2), p.215-222 |
| issn | 1053-8569 1099-1557 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5063172 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Animals Commentaries Data Interpretation, Statistical Data Mining - methods Humans Incidence methodology Observed-to-expected pharmacoepidemiology Pharmacoepidemiology - methods Uncertainty uncertainty analyses Vaccines - adverse effects |
| title | Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T01%3A08%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacoepidemiological%20considerations%20in%20observed-to-expected%20analyses%20for%20vaccines&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=Mahaux,%20Olivia&rft.date=2016-02&rft.volume=25&rft.issue=2&rft.spage=215&rft.epage=222&rft.pages=215-222&rft.issn=1053-8569&rft.eissn=1099-1557&rft_id=info:doi/10.1002/pds.3918&rft_dat=%3Cproquest_pubme%3E3934990001%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760722076&rft_id=info:pmid/26602179&rfr_iscdi=true |